JP2018518196A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518196A5 JP2018518196A5 JP2018513266A JP2018513266A JP2018518196A5 JP 2018518196 A5 JP2018518196 A5 JP 2018518196A5 JP 2018513266 A JP2018513266 A JP 2018513266A JP 2018513266 A JP2018513266 A JP 2018513266A JP 2018518196 A5 JP2018518196 A5 JP 2018518196A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- seq
- hiv
- silencing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562163332P | 2015-05-18 | 2015-05-18 | |
| US62/163,332 | 2015-05-18 | ||
| PCT/US2016/017931 WO2016186708A1 (en) | 2015-05-18 | 2016-02-15 | Gene therapeutic for the treatment of hiv and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018518196A JP2018518196A (ja) | 2018-07-12 |
| JP2018518196A5 true JP2018518196A5 (enExample) | 2019-03-28 |
Family
ID=55538591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513266A Ceased JP2018518196A (ja) | 2015-05-18 | 2016-02-15 | Ｈｉｖの治療のための遺伝子治療法およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20180112220A1 (enExample) |
| EP (1) | EP3294895B1 (enExample) |
| JP (1) | JP2018518196A (enExample) |
| CN (1) | CN108026543A (enExample) |
| AU (1) | AU2016265003A1 (enExample) |
| CA (1) | CA2986469A1 (enExample) |
| ES (1) | ES2833449T3 (enExample) |
| HK (1) | HK1247963A1 (enExample) |
| WO (1) | WO2016186708A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11980663B2 (en) | 2015-07-08 | 2024-05-14 | American Gene Technologies International Inc. | HIV pre-immunization and immunotherapy |
| JP7153332B2 (ja) | 2016-02-08 | 2022-10-14 | アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド | Ｈｉｖワクチン接種および免疫療法 |
| CA3028982A1 (en) | 2016-07-08 | 2018-01-11 | American Gene Technologies International Inc. | Hiv pre-immunization and immunotherapy |
| US20200061117A1 (en) * | 2017-05-08 | 2020-02-27 | The Regents Of The University Of California | Protective Chimeric Antigen Receptor Stem Cell Gene Therapy for Viral Infection |
| CA3070242A1 (en) | 2017-07-18 | 2019-01-24 | Calimmune, Inc. | Compositions and methods for treating beta-hemoglobinopathies |
| EP3897831A1 (en) | 2018-12-23 | 2021-10-27 | CSL Behring LLC | Donor t-cells with kill switch |
| CN113518825A (zh) | 2018-12-23 | 2021-10-19 | 美国杰特贝林生物制品有限公司 | Wiskott-aldrich综合征的造血干细胞基因疗法 |
| WO2021263070A1 (en) | 2020-06-26 | 2021-12-30 | Csl Behring Llc | Donor t-cells with kill switch |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| US7737124B2 (en) * | 2001-09-13 | 2010-06-15 | California Institute Of Technology | Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell |
| CA2516188C (en) * | 2003-02-14 | 2012-04-17 | University Of South Florida | Chitosan-derivatives for gene delivery and expression |
| US20120201794A1 (en) * | 2009-07-15 | 2012-08-09 | Calimmune Inc. | Dual vector for inhibition of human immunodeficiency virus |
| WO2016029275A1 (en) * | 2014-08-28 | 2016-03-03 | Newsouth Innovations Pty Limited | Treatment of hiv |
-
2016
- 2016-02-15 CA CA2986469A patent/CA2986469A1/en not_active Abandoned
- 2016-02-15 EP EP16710350.6A patent/EP3294895B1/en not_active Not-in-force
- 2016-02-15 JP JP2018513266A patent/JP2018518196A/ja not_active Ceased
- 2016-02-15 HK HK18107365.2A patent/HK1247963A1/zh unknown
- 2016-02-15 ES ES16710350T patent/ES2833449T3/es active Active
- 2016-02-15 AU AU2016265003A patent/AU2016265003A1/en not_active Abandoned
- 2016-02-15 WO PCT/US2016/017931 patent/WO2016186708A1/en not_active Ceased
- 2016-02-15 CN CN201680042303.7A patent/CN108026543A/zh active Pending
-
2017
- 2017-11-13 US US15/810,222 patent/US20180112220A1/en not_active Abandoned
-
2020
- 2020-10-21 US US17/075,802 patent/US20210032627A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11291710B2 (en) | Methods and compositions for RNA-guided treatment of HIV infection | |
| AU2017219605B2 (en) | Excision of retroviral nucleic acid sequences | |
| EP3407918A1 (en) | Methods and compositions for rna-guided treatment of hiv infection | |
| JP2012533299A5 (enExample) | ||
| ES2833449T3 (es) | Terapia génica para el tratamiento del VIH y usos de la misma | |
| US20200140865A1 (en) | An hiv-1 eradication strategy employing nanoformulated anti-retroviral drugs and gene editing agents | |
| Lori et al. | Gene therapy approaches to HIV infection | |
| US20240261436A1 (en) | Gene editing therapy for hiv infection via dual targeting of hiv genome and ccr5 | |
| Seo et al. | Protection against lethal vaccinia virus infection in mice using an siRNA targeting the A5R gene | |
| HK40114560A (en) | Methods and compositions for rna-guided treatment of hiv infection | |
| US20150050265A1 (en) | Anti-mcpip therapies for ocular neovascularization | |
| HK40000290A (en) | Excision of retroviral nucleic acid sequences |